Literature DB >> 12622201

Effect of preservative, antioxidant and viscolizing agents on in vitro transcorneal permeation of ketorolac tromethamine.

Manjusha Malhotra1, D K Majumdar.   

Abstract

The influence of formulation additives, e.g. preservative, antioxidant and viscolizing agents on in vitro transcorneal permeation of ketorolac tromethamine from 0.5%(w/v) aqueous drop was studied using goat cornea. Permeation characteristics of drug, from selected formulations, through excised rabbit cornea were also evaluated. Aqueous solution of ketorolac tromethamine (0.5% w/v), pH 6.5 or 7.0 having ionic strength 0.2, was prepared. To this solution perservatives either alone or in combination with other additives were added to have drops of various composition. Permeation studies with goat cornea showed maximum permeation of ketorolac tromethamine from formulation containing benzalkonium chloride and disodium edetate. Increase in viscosity of drop resulted in decreased permeation of drug. Formulation containing benzalkonium chloride and disodium edetate also increased permeation of drug through rabbit cornea. Cumulative permeation of drug through rabbit cornea was found to be 2.3-2.4 fold higher than that observed with goat cornea.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12622201

Source DB:  PubMed          Journal:  Indian J Exp Biol        ISSN: 0019-5189            Impact factor:   0.818


  6 in total

Review 1.  In vitro and ex vivo corneal penetration and absorption models.

Authors:  Priyanka Agarwal; Ilva D Rupenthal
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

2.  In vivo ocular availability of ketorolac following ocular instillations of aqueous, oil, and ointment formulations to normal corneas of rabbits: a technical note.

Authors:  Manjusha Malhotra; Dipak K Majumdar
Journal:  AAPS PharmSciTech       Date:  2005-10-24       Impact factor: 3.246

3.  Aqueous, oil, and ointment formulations of ketorolac: efficacy against prostaglandin E2-induced ocular inflammation and safety: a technical note.

Authors:  Manjusha Malhotra; Dipak K Majumdar
Journal:  AAPS PharmSciTech       Date:  2006       Impact factor: 3.246

4.  Ocular pharmacokinetics of 0.45% ketorolac tromethamine.

Authors:  Mayssa Attar; Rhett Schiffman; Lisa Borbridge; Quinn Farnes; Devin Welty
Journal:  Clin Ophthalmol       Date:  2010-12-01

Review 5.  Topical ocular delivery of NSAIDs.

Authors:  Munish Ahuja; Avinash S Dhake; Surendra K Sharma; Dipak K Majumdar
Journal:  AAPS J       Date:  2008-04-25       Impact factor: 4.009

6.  Design and Evaluation of Voriconazole Eye Drops for the Treatment of Fungal Keratitis.

Authors:  Sakshi Malhotra; Anubha Khare; Kanchan Grover; Inderbir Singh; Pravin Pawar
Journal:  J Pharm (Cairo)       Date:  2014-04-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.